Heijmans overhandigt resultaten intern onderzoek aan Nederlandse Mededingingsautoriteit NMa
May 03, 2004 12:59 ET
|
Heijmans NV
Op 25 februari 2004 heeft Heijmans zich tot de NMa gewend en aangekondigd een onderzoek te zullen starten naar de gang van zaken rond concurrentie bij aanbestedingen bij al haar Nederlandse...
CDMA450 Deployments Accelerate Around the World
May 03, 2004 12:25 ET
|
CDMA Development Group
COSTA MESA, Calif., May 3, 2004 (PRIMEZONE) -- The CDMA Development Group (CDG) (www.cdg.org) reported today that across Europe, Asia, Latin America, and Africa, there are seven commercial CDMA2000...
CORRECTION: Chicago Law Firm Much Shelist Announces Class Period for Shareholder Class Action Suit on Behalf of Investors Who Purchased Nortel Networks Corporation -- NT
May 03, 2004 12:22 ET
|
Much Shelist Freed Denenberg Ament & Rubenstein
CHICAGO, May 3, 2004 (PRIMEZONE) -- Much Shelist Freed Denenberg Ament & Rubenstein, P.C. announces that a class action lawsuit is pending in the United States District Court for the Southern...
Integra LifeSciences Launches LICOX(R) PMO Catheter
May 03, 2004 12:15 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., May 3, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it plans to market and sell the LICOX(R) PMO, a next-generation catheter and...
The Secrets of Time
May 03, 2004 12:00 ET
|
Xlibris
WOODLAND HILLS, Calif., May 3, 2004 (PRIMEZONE) -- The president of the United States is an alcoholic, a megalomaniac, a manipulator, and a liar. But he isn't completely bad. He is, after all,...
Basilea's Antibiotic BAL5788 - Unlikely to Induce Resistance in MRSA
May 03, 2004 11:50 ET
|
Basilea Pharmaceutica Ltd
BASEL, Switzerland, May 03, 2004 (PRIMEZONE) -- Basilea Pharmaceutica AG presented in vitro data yesterday at the 14th European Congress on Clinical Microbiology and Infectious Diseases (ECCMID),...
Mobistar poursuit sa croissance
May 03, 2004 11:31 ET
|
Orange Belgium
Mobistar comptait au 31 mars 2004 un total de 2.647.157 clients actifs, en comparaison avec 2.359.360 clients actifs au 31 mars 2003. Il s'agit d'un accroissement de 287.797 cartes en douze...
Basilea's Antibiotic BAL5788 - Unlikely to Induce Resistance in MRSA
May 03, 2004 11:30 ET
|
Basilea Pharmaceutica AG, Allschwil
Basel, Switzerland, 3 May 2004
Basilea Pharmaceutica AG presented in vitro data yesterday at the 14th European Congress on Clinical Microbiology and Infectious Diseases (ECCMID),...
Basileas Antibiotikum (BAL5788) entwickelt höchstwahrscheinlich keine Resistenz gegen MRSA
May 03, 2004 11:30 ET
|
Basilea Pharmaceutica AG, Allschwil
Basel, 3. Mai 2004
Gestern am 2. Mai präsentierte Basilea Pharmaceutica AG am 14. Europäischen Kongress für Klinische Mikrobiologie und Infektionskrankheiten (ECCMID) neue Daten zu BAL5788,...
Mobistar poursuit sa croissance
May 03, 2004 11:28 ET
|
Orange Belgium
Mobistar comptait au 31 mars 2004 un total de 2.647.157 clients actifs, en comparaison avec 2.359.360 clients actifs au 31 mars 2003. Il s'agit d'un accroissement de 287.797 cartes en douze...
- September 28, 2024 10:00 ET Argy Bargy Completes IDO, Setting up its Revolutionary Match3 Collection Card RPG in the Web3 Gaming Space
- September 28, 2024 08:30 ET Montreal hosts the 4th International Symposium on Arthrogryposis Multiplex Congenita (AMC)